MedicaidPrior AuthMedium impact
Cosela™ (trilaciclib) (Revised)
Humana·LA · Oncology, Hematology·Medicaid
Effective date
Nov 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Louisiana now requires prior authorization for Cosela (trilaciclib) injections used to prevent chemotherapy-induced bone marrow suppression in extensive-stage small cell lung cancer patients. Coverage requires specific diagnosis and chemotherapy regimen criteria to be met.
Action Required
By November 1, 2025: Billing team must implement prior authorization requirements for Cosela (trilaciclib) claims for Louisiana Medicaid patients. Update billing system to flag extensive-stage small cell lung cancer patients receiving platinum/etoposide or topotecan chemotherapy regimens. Providers must obtain prior auth before administering Cosela or claims will be denied.